|
2025-04-02 |
2025-04-01 |
VP
Vente planifiée
|
Hirano Patricia C
SEE REMARKS
Dirigeant
|
3 782
-12.3%
70,11
265 156 USD
|
3 782
-12.3%
|
70,11
|
265 156 USD
|
|
|
2025-03-31 |
2025-03-28 |
V
Vente
|
Pauls Matthew
Administrateur non-exécutif
|
5 937
-47.7%
71,55
424 797 USD
|
5 937
-47.7%
|
71,55
|
424 797 USD
|
|
|
2025-03-31 |
2025-03-28 |
VP
Vente planifiée
|
Hirano Patricia C
SEE REMARKS
Dirigeant
|
2 691
-8.0%
73,60
198 058 USD
|
2 691
-8.0%
|
73,60
|
198 058 USD
|
|
|
2025-03-31 |
2025-03-28 |
VP
Vente planifiée
|
Hirano Patricia C
SEE REMARKS
Dirigeant
|
9 253
-21.6%
69,52
643 246 USD
|
9 253
-21.6%
|
69,52
|
643 246 USD
|
|
|
2025-03-31 |
2025-03-28 |
VP
Vente planifiée
|
Hirano Patricia C
SEE REMARKS
Dirigeant
|
12 324
-22.4%
68,92
849 386 USD
|
12 324
-22.4%
|
68,92
|
849 386 USD
|
|
|
2025-03-31 |
2025-03-28 |
VP
Vente planifiée
|
Hirano Patricia C
SEE REMARKS
Dirigeant
|
3 394
-5.8%
67,46
228 946 USD
|
3 394
-5.8%
|
67,46
|
228 946 USD
|
|
|
2025-03-28 |
2025-03-28 |
V
Vente
|
Vivo Opportunity, LLC
Actionnaire important
|
333 557
-7.0%
70,60
23 549 124 USD
|
333 557
-7.0%
|
70,60
|
23 549 124 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Manning Meredith
Chief Commercial Officer
Dirigeant
|
37 000
-44.9%
67,04
2 480 436 USD
|
37 000
-44.9%
|
67,04
|
2 480 436 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Manning Meredith
Chief Commercial Officer
Dirigeant
|
34
-0.1%
72,64
2 470 USD
|
34
-0.1%
|
72,64
|
2 470 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Manning Meredith
Chief Commercial Officer
Dirigeant
|
225
-0.5%
71,74
16 142 USD
|
225
-0.5%
|
71,74
|
16 142 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Manning Meredith
Chief Commercial Officer
Dirigeant
|
155
-0.3%
70,73
10 964 USD
|
155
-0.3%
|
70,73
|
10 964 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Manning Meredith
Chief Commercial Officer
Dirigeant
|
1 505
-3.2%
69,84
105 105 USD
|
1 505
-3.2%
|
69,84
|
105 105 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Manning Meredith
Chief Commercial Officer
Dirigeant
|
2 599
-5.2%
68,79
178 780 USD
|
2 599
-5.2%
|
68,79
|
178 780 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Manning Meredith
Chief Commercial Officer
Dirigeant
|
1 976
-3.8%
67,70
133 777 USD
|
1 976
-3.8%
|
67,70
|
133 777 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Manning Meredith
Chief Commercial Officer
Dirigeant
|
1 087
-2.1%
66,79
72 602 USD
|
1 087
-2.1%
|
66,79
|
72 602 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Manning Meredith
Chief Commercial Officer
Dirigeant
|
668
-1.2%
65,97
44 067 USD
|
668
-1.2%
|
65,97
|
44 067 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Mackaness James H
CHIEF FINANCIAL OFFICER
Dirigeant
|
8 044
-7.1%
70,80
569 494 USD
|
8 044
-7.1%
|
70,80
|
569 494 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Mackaness James H
CHIEF FINANCIAL OFFICER
Dirigeant
|
36 157
-24.2%
70,03
2 531 919 USD
|
36 157
-24.2%
|
70,03
|
2 531 919 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Mackaness James H
CHIEF FINANCIAL OFFICER
Dirigeant
|
25 799
-14.7%
69,07
1 782 022 USD
|
25 799
-14.7%
|
69,07
|
1 782 022 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Mackaness James H
CHIEF FINANCIAL OFFICER
Dirigeant
|
86
-0.1%
72,64
6 247 USD
|
86
-0.1%
|
72,64
|
6 247 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Mackaness James H
CHIEF FINANCIAL OFFICER
Dirigeant
|
563
-0.5%
71,74
40 391 USD
|
563
-0.5%
|
71,74
|
40 391 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Mackaness James H
CHIEF FINANCIAL OFFICER
Dirigeant
|
387
-0.4%
70,73
27 374 USD
|
387
-0.4%
|
70,73
|
27 374 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Mackaness James H
CHIEF FINANCIAL OFFICER
Dirigeant
|
3 762
-3.4%
69,84
262 727 USD
|
3 762
-3.4%
|
69,84
|
262 727 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Mackaness James H
CHIEF FINANCIAL OFFICER
Dirigeant
|
6 498
-5.6%
68,79
446 985 USD
|
6 498
-5.6%
|
68,79
|
446 985 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Mackaness James H
CHIEF FINANCIAL OFFICER
Dirigeant
|
4 940
-4.1%
67,70
334 441 USD
|
4 940
-4.1%
|
67,70
|
334 441 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Mackaness James H
CHIEF FINANCIAL OFFICER
Dirigeant
|
2 717
-2.2%
66,79
181 473 USD
|
2 717
-2.2%
|
66,79
|
181 473 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Mackaness James H
CHIEF FINANCIAL OFFICER
Dirigeant
|
1 669
-1.3%
65,97
110 102 USD
|
1 669
-1.3%
|
65,97
|
110 102 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Yen Kristen
SEE REMARKS
Dirigeant
|
23 475
-45.5%
66,95
1 571 717 USD
|
23 475
-45.5%
|
66,95
|
1 571 717 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Yen Kristen
SEE REMARKS
Dirigeant
|
50 156
-49.3%
66,00
3 310 080 USD
|
50 156
-49.3%
|
66,00
|
3 310 080 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Yen Kristen
SEE REMARKS
Dirigeant
|
91
-0.1%
72,64
6 610 USD
|
91
-0.1%
|
72,64
|
6 610 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Yen Kristen
SEE REMARKS
Dirigeant
|
597
-1.0%
71,74
42 831 USD
|
597
-1.0%
|
71,74
|
42 831 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Yen Kristen
SEE REMARKS
Dirigeant
|
411
-0.7%
70,73
29 072 USD
|
411
-0.7%
|
70,73
|
29 072 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Yen Kristen
SEE REMARKS
Dirigeant
|
3 990
-6.0%
69,84
278 650 USD
|
3 990
-6.0%
|
69,84
|
278 650 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Yen Kristen
SEE REMARKS
Dirigeant
|
6 891
-9.4%
68,79
474 019 USD
|
6 891
-9.4%
|
68,79
|
474 019 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Yen Kristen
SEE REMARKS
Dirigeant
|
5 239
-6.7%
67,70
354 684 USD
|
5 239
-6.7%
|
67,70
|
354 684 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Yen Kristen
SEE REMARKS
Dirigeant
|
2 881
-3.5%
66,79
192 427 USD
|
2 881
-3.5%
|
66,79
|
192 427 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Yen Kristen
SEE REMARKS
Dirigeant
|
1 769
-2.1%
65,97
116 699 USD
|
1 769
-2.1%
|
65,97
|
116 699 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Huang Michael F.
Sr. VP of Clinical Development
Dirigeant
|
10 000
-21.4%
70,03
700 330 USD
|
10 000
-21.4%
|
70,03
|
700 330 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Huang Michael F.
Sr. VP of Clinical Development
Dirigeant
|
19
-0.1%
72,64
1 380 USD
|
19
-0.1%
|
72,64
|
1 380 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Huang Michael F.
Sr. VP of Clinical Development
Dirigeant
|
125
-0.3%
71,74
8 968 USD
|
125
-0.3%
|
71,74
|
8 968 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Huang Michael F.
Sr. VP of Clinical Development
Dirigeant
|
86
-0.2%
70,73
6 083 USD
|
86
-0.2%
|
70,73
|
6 083 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Huang Michael F.
Sr. VP of Clinical Development
Dirigeant
|
836
-2.2%
69,84
58 384 USD
|
836
-2.2%
|
69,84
|
58 384 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Huang Michael F.
Sr. VP of Clinical Development
Dirigeant
|
1 444
-3.7%
68,79
99 330 USD
|
1 444
-3.7%
|
68,79
|
99 330 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Huang Michael F.
Sr. VP of Clinical Development
Dirigeant
|
1 098
-2.7%
67,70
74 335 USD
|
1 098
-2.7%
|
67,70
|
74 335 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Huang Michael F.
Sr. VP of Clinical Development
Dirigeant
|
604
-1.5%
66,79
40 342 USD
|
604
-1.5%
|
66,79
|
40 342 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Huang Michael F.
Sr. VP of Clinical Development
Dirigeant
|
371
-0.9%
65,97
24 475 USD
|
371
-0.9%
|
65,97
|
24 475 USD
|
|
|
2025-03-31 |
2025-03-27 |
VP
Vente planifiée
|
Hirano Patricia C
SEE REMARKS
Dirigeant
|
15 145
-21.4%
72,50
1 098 013 USD
|
15 145
-21.4%
|
72,50
|
1 098 013 USD
|
|
|
2025-03-31 |
2025-03-27 |
VP
Vente planifiée
|
Hirano Patricia C
SEE REMARKS
Dirigeant
|
24 989
-26.1%
70,18
1 753 628 USD
|
24 989
-26.1%
|
70,18
|
1 753 628 USD
|
|
|
2025-03-31 |
2025-03-27 |
VP
Vente planifiée
|
Hirano Patricia C
SEE REMARKS
Dirigeant
|
24 776
-20.5%
67,47
1 671 629 USD
|
24 776
-20.5%
|
67,47
|
1 671 629 USD
|
|
|
2025-03-31 |
2025-03-27 |
VP
Vente planifiée
|
Hirano Patricia C
SEE REMARKS
Dirigeant
|
46 214
-27.7%
66,39
3 068 147 USD
|
46 214
-27.7%
|
66,39
|
3 068 147 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Hirano Patricia C
SEE REMARKS
Dirigeant
|
73
-0.1%
72,64
5 303 USD
|
73
-0.1%
|
72,64
|
5 303 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Hirano Patricia C
SEE REMARKS
Dirigeant
|
478
-0.5%
71,74
34 293 USD
|
478
-0.5%
|
71,74
|
34 293 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Hirano Patricia C
SEE REMARKS
Dirigeant
|
329
-0.3%
70,73
23 272 USD
|
329
-0.3%
|
70,73
|
23 272 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Hirano Patricia C
SEE REMARKS
Dirigeant
|
3 198
-3.2%
69,84
223 339 USD
|
3 198
-3.2%
|
69,84
|
223 339 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Hirano Patricia C
SEE REMARKS
Dirigeant
|
5 524
-5.3%
68,79
379 985 USD
|
5 524
-5.3%
|
68,79
|
379 985 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Hirano Patricia C
SEE REMARKS
Dirigeant
|
4 199
-3.9%
67,70
284 275 USD
|
4 199
-3.9%
|
67,70
|
284 275 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Hirano Patricia C
SEE REMARKS
Dirigeant
|
2 310
-2.1%
66,79
154 289 USD
|
2 310
-2.1%
|
66,79
|
154 289 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Hirano Patricia C
SEE REMARKS
Dirigeant
|
1 418
-1.3%
65,97
93 544 USD
|
1 418
-1.3%
|
65,97
|
93 544 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Anish Bhatnagar
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
199 226
-25.7%
69,30
13 805 904 USD
|
199 226
-25.7%
|
69,30
|
13 805 904 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Anish Bhatnagar
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
8 423
-1.1%
67,37
567 458 USD
|
8 423
-1.1%
|
67,37
|
567 458 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Anish Bhatnagar
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
209 689
-21.1%
66,33
13 908 797 USD
|
209 689
-21.1%
|
66,33
|
13 908 797 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Anish Bhatnagar
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
106 471
-9.7%
65,81
7 007 059 USD
|
106 471
-9.7%
|
65,81
|
7 007 059 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Anish Bhatnagar
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
732
-0.1%
72,64
53 172 USD
|
732
-0.1%
|
72,64
|
53 172 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Anish Bhatnagar
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
4 782
-0.8%
71,74
343 076 USD
|
4 782
-0.8%
|
71,74
|
343 076 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Anish Bhatnagar
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
3 291
-0.6%
70,73
232 786 USD
|
3 291
-0.6%
|
70,73
|
232 786 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Anish Bhatnagar
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
31 980
-5.2%
69,84
2 233 390 USD
|
31 980
-5.2%
|
69,84
|
2 233 390 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Anish Bhatnagar
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
55 234
-8.2%
68,79
3 799 442 USD
|
55 234
-8.2%
|
68,79
|
3 799 442 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Anish Bhatnagar
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
41 989
-5.9%
67,70
2 842 685 USD
|
41 989
-5.9%
|
67,70
|
2 842 685 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Anish Bhatnagar
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
23 095
-3.1%
66,79
1 542 552 USD
|
23 095
-3.1%
|
66,79
|
1 542 552 USD
|
|
|
2025-03-31 |
2025-03-27 |
V
Vente
|
Anish Bhatnagar
CHIEF EXECUTIVE OFFICER
Administrateur exécutif
|
14 183
-1.9%
65,97
935 640 USD
|
14 183
-1.9%
|
65,97
|
935 640 USD
|
|
|
2025-03-28 |
2025-03-27 |
V
Vente
|
Vivo Opportunity, LLC
Actionnaire important
|
1 100 000
-18.7%
67,80
74 580 000 USD
|
1 100 000
-18.7%
|
67,80
|
74 580 000 USD
|
|
|
2025-03-28 |
2025-03-26 |
V
Vente
|
Vivo Opportunity, LLC
Actionnaire important
|
400 000
-6.4%
65,80
26 320 000 USD
|
400 000
-6.4%
|
65,80
|
26 320 000 USD
|
|
|
2025-01-06 |
2025-01-03 |
V
Vente
|
Mackaness James H
CHIEF FINANCIAL OFFICER
Dirigeant
|
3 791
-3.3%
46,18
175 055 USD
|
3 791
-3.3%
|
46,18
|
175 055 USD
|
|
|
2025-01-06 |
2025-01-03 |
V
Vente
|
Yen Kristen
SEE REMARKS
Dirigeant
|
2 340
-3.0%
46,18
108 053 USD
|
2 340
-3.0%
|
46,18
|
108 053 USD
|
|
|
2025-01-06 |
2025-01-03 |
V
Vente
|
Hirano Patricia C
SEE REMARKS
Dirigeant
|
1 459
-1.4%
46,18
67 371 USD
|
1 459
-1.4%
|
46,18
|
67 371 USD
|
|
